Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 1504
Journal of Traditional Medicine & Clinical Naturopathy peer review process verified at publons
Indexed In
- CAS Source Index (CASSI)
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Genamics JournalSeek
- RefSeek
- Directory of Research Journal Indexing (DRJI)
- Hamdard University
- EBSCO A-Z
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Adjunctive traditional Chinese medicine therapy improves survival in patients with lung cancer
6th International Conference and Exhibition on Traditional & Alternative Medicine
Hsuan-Shu Shen and Shu-Hui Wen
Tzu Chi University, Taiwan
Posters & Accepted Abstracts: J Tradi Med Clin Natur
Abstract
Background: Traditional Chinese medicine (TCM) is widely used by patients suffered from lung cancer. Evidence shows that TCM can alleviate the complications of the lung cancer, but there is little large-scale well-designed study to evaluate the clinical effect of TCM on survival time. Method: We conducted a retrospective cohort study by using the data provided by Health and Welfare Data Science Center to evaluate the survival time of the patients with lung cancer from 2001 to 2010. The patients were divided into TCM users (who use TCM in the first 90 days after diagnosed) and non TCM users(who do not use TCM after diagnosed). We balanced the baseline characteristic between two groups by propensity-score matching method and compare the survival curve by Kaplan-Meier curve and stratified log-rank test. Robust cox regression was used to estimate the hazard ratio (HR) with 95% confidence interval (CI). Results: There were 2009 patients and 422 patients were TCM users and 1587 patients were non TCM users. There was no significant difference in age, gender, stage, treatment type and co-morbidities between two groups. The mean survival time is significantly longer in TCM users than in non TCM users with 715 days and 605 days respectively. Compared to non TCM users, TCM users were significantly associated with a decrease risk of death (adjusted HR=0.82, 95% CI=0.73-0.92) with multivariate adjustment. Among the late stage, there was still a significantly protective effect by using TCM with multivariate adjustment (stage III, adjusted HR=0.72, 95% CI=0.57-0.92, stage IV, adjusted HR=0.87, 95% CI=0.75-1.00). Conclusion: Our study showed that adjunctive TCM therapy can lengthen the survival time in patients with lung cancer. The findings may be helpful to the physicians when treating the patients with lung cancer.Biography
Hsuan-Shu Shen is an experienced Chinese Medicine Physician in Hualien Tzu Chi Hospital. He is interested in the effect of the Traditional Chinese Medicine, especially in treating cancer patients. He is the Principal Investigator of the project about the efficacy of combined using Traditional Chinese Medicine among patients with cancer and willing to make contributions for treating cancer.
Email: hsuanshushen@gmail.com
